Clinical Trial Name - Study Evaluating Enbrel (Etanercept) in Adult Patients With Plaque Psoriasis
| Original Study ID : 0881A-101789 |
| NCT ID : NCT00227240 |
| Brief Title : Study Evaluating Enbrel (Etanercept) in Adult Patients With Plaque Psoriasis |
| Official Title : Observational Study With Enbrel (Etanercept) in Adult Patients With Plaque Psoriasis |
| Brief Summary :
The purpose of this study is to investigate the incidences of adverse events for patients
with plaque psoriasis treated with Enbrel under usual care settings.
|
| Source : Wyeth |
| Overall Status : Recruiting |
| Start Date : April 2005 |
| End Date : April 2009 |
| Completion Date : April 2009 |
| Official Title : N/A |
| Phase : Observational |
| Study Design : Cohort, Prospective |
| Enrollment : 750 |
| Verification Date : December 2007 |
| First Received Date : September 13, 2005 |
| Trial Eligibility |
Criteria :
Inclusion Criteria:
- Proven diagnosis of Plaque Psoriasis
Exclusion Criteria:
- Contraindications according to SmPC of Enbrel
|
| Gender : Both |
| Minimum Age : 18 Years |
| Maximum Age : N/A |
| Healthy Volunteers : No |
| Facilities |
| Status : Recruiting |
| City : Bonn |
| State : Nordrheim-Westfalen |
| Zip Code : 53105 |
| Country : Germany |
|
| Interventions |
| Type : Drug |
| Name : Enbrel |
| Description : 25mg administered twice weekly |
|
